Preclinical and clinical efficacy of entrectinib in primary and metastatic brain tumors harboring NTRK, ROS1, or ALK gene fusions Meeting Abstract
| Authors: | Rangaraju, S.; Farago, A.; Heym, K. M.; Ahn, M.; Drilon, A.; Potts, S.; Hornby, Z.; Multani, P.; Li, G. |
| Abstract Title: | Preclinical and clinical efficacy of entrectinib in primary and metastatic brain tumors harboring NTRK, ROS1, or ALK gene fusions |
| Meeting Title: | 5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies (WFNOS) |
| Journal Title: | Neuro-Oncology |
| Volume: | 19 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2017 May 4-7 |
| Meeting Location: | Zurich, Switzerland |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-05-01 |
| Start Page: | iii106 |
| Language: | English |
| ACCESSION: | WOS:000402732900406 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/nox036.404 |
| PMCID: | PMC5464020 |
| Notes: | Meeting Abstract: P14.19 -- Source: Wos |
